SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nexus Surgical And Medicare Ltd (538874)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 538874 NSE: Trading | Small Cap | Nexus Surgical & Med Share Price

₹19.65 -1.85 (-8.60%)

As on 24-Jun'26 16:59

Nexus Surgical And Medicare Ltd (538874)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 538874 NSE: Trading | Small Cap | Nexus Surgical & Med Share Price

₹19.65 -1.85 (-8.60%)

As on 24-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹11 Cr.
Current Price
₹19.7
52-Week Low / High
₹13 / 26
TTM EPS
₹1.4
TTM Sales
₹7.9 Cr.
Book Value per Share
₹3.3
P/E Ratio
14.61
Lower than its 5-year historical median
Industry PE
37.6
Price to Book (P/B)
5.97
Lower than its 5-year historical median
Price to Sales (P/S)
1.37
Lower than its 5-year historical median
EV/EBITDA
10.34
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
61.03%
Outperforms industry median
Return on Capital Employed (ROCE)
83.16%
Outperforms industry median
Return on Assets (ROA)
24.47%
Operating Profit Margin
12.2%
Net Profit Margin
8.69%
Gross Profit Margin
11.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
64.84%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
148.15%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
138.1%
Asset Quality
Promoter Holding
18.73%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-4 Cr.
Equity
₹5.5 Cr.
Face Value
₹10
All Time Low / High
₹2.28 / 64.70

Nexus Surgical And Medicare stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Nexus Surgical And Medicare Ltd a good quality company?
Nexus Surgical And Medicare Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Nexus Surgical And Medicare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Nexus Surgical And Medicare Ltd vs industry peers?
Nexus Surgical And Medicare Ltd revenue CAGR is 27.02%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Nexus Surgical And Medicare Ltd?
Promoters hold 18.73% of the Nexus Surgical And Medicare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Nexus Surgical And Medicare Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -8.8% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nexus Surgical And Medicare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 1.4%-3.2%-5.8%-2%-209.8%0%1,048%86%64.5%83.2%-
Value Creation
Index
-0.9-1.2-1.4-1.1NANA73.95.13.64.9-

Growth Parameters

Sales 0.30.312.11.73.72.41.63.55.78
Sales YoY Gr.--9.1%226.7%118.4%-19.2%116.2%-35.8%-35.4%123.9%64.8%-
Adj EPS 0.1-0.4-0.6-0.2-2.80.30.50.30.40.91.4
YoY Gr.--488.9%NANANANA89.3%-41.5%29%135%-
BVPS (₹) 10.3109.49.2-0.5-0.20.30.711.93.3
Adj Net
Profit
0.1-0.2-0.3-0.1-1.60.20.30.20.20.51
Cash Flow from Ops. -0-0.2-0.100.20.2-0.10.6-0.40.1-
Debt/CF from Ops. -2.8-1.7-3.612.7000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 37.3%27%33.6%64.8%
Adj EPS 29.8%NA21.1%135%
BVPS-16.9%NA80.5%88.4%
Share Price -8.9% 44.2% 23.6% 12.1%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.9-3.5-6.1-2.2-65-83.3781.463.94863.351.6
Op. Profit
Mgn %
24.6-59.5-39-8.44.24.415.414.18.112.212.2
Net Profit
Mgn %
14.9-63.2-33.3-5.2-89.54.112.1116.399.4
Debt to
Equity
00.10.10.10000000
Working Cap
Days
3384361142224411952479311084
Cash Conv.
Cycle
22528331-17-125-92-688-1,054-162-5546

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.330.300.982.141.733.742.401.553.475.72
Operating Expenses + 0.250.491.362.321.663.582.031.343.205.05
Manufacturing Costs000.010000.030.030.190.50
Material Costs0.080.290.962.130.781.0200.450.591.87
Employee Cost 0.080.080.220.090.150.320.220.250.240.41
Other Costs 0.090.120.160.100.732.241.770.612.182.26
Operating Profit 0.08-0.18-0.38-0.180.070.160.370.220.270.67
Operating Profit Margin (%) 24.6%-59.5%-39.0%-8.4%4.2%4.4%15.4%14.0%7.8%11.8%
Other Income + 000.060.0800.010.020.010.030.01
Exceptional Items 0000-5.3500000
Interest 0.010.010000000.010.01
Depreciation 0000000000
Profit Before Tax 0.07-0.19-0.32-0.11-5.280.170.390.230.290.67
Tax 0.0200.0100.020.020.100.060.080.17
Profit After Tax 0.05-0.19-0.33-0.11-5.300.150.290.170.210.50
PAT Margin (%) 14.9%-63.2%-33.3%-5.2%-305.0%4.1%12.1%11.0%6.1%8.7%
Adjusted EPS (₹)0.1-0.4-0.6-0.2-9.70.30.50.30.40.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Nexus Surgical & Med - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 5.645.475.155.03-0.26-0.110.180.350.571.06
Share Capital 5.475.475.475.475.475.475.475.475.475.47
Reserves 0.17-0-0.33-0.44-5.73-5.58-5.29-5.12-4.91-4.41
Debt +0.090.290.250.26000000
Long Term Debt0.09000000000
Short Term Debt00.290.250.26000000
Minority Interest0000000000
Trade Payables0.020.180.190.200.4611.780.561.241.18
Others Liabilities 0.02-0.02-0.01-0.0100.030.03-0-0.010.03
Total Liabilities 5.775.925.575.480.200.921.990.911.802.27

Fixed Assets

Net Fixed Assets +0.030.030.020.020.020.020.010.020.020.02
Gross Block0.280.280.280.280.280.280.280.290.290.30
Accumulated Depreciation0.250.250.260.260.260.260.270.270.270.27
CWIP 5.355.355.355.35000000
Investments 0000000000
Inventories0.030.110.040000.430.070.400.43
Trade Receivables0.230.240.100.0400.1200.040.751.34
Cash Equivalents 0.090.120.010.040.020.220.110.650.230.33
Others Assets 0.050.070.050.030.160.571.440.120.390.15
Total Assets 5.775.925.575.480.200.921.990.911.802.27

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0.03-0.17-0.070.020.240.20-0.110.55-0.410.10
PBT 0.07-0.19-0.32-0.110.070.170.390.230.290.67
Adjustment 0.01000000000
Changes in Working Capital -0.080.020.250.130.170.03-0.50.32-0.71-0.57
Tax Paid -0.04000000000
Cash Flow From Investing Activity + 000000-0-0.01-0-0.01
Capex 000000-0-0.01-0-0.01
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity + 0.090.20-0.040.01-0.2600000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -0.01000000000
Dividend Paid 0000000000
Others 0.090.20-0.040.01-0.2600000
Net Cash Flow 0.050.03-0.110.03-0.020.20-0.110.54-0.420.10

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.87-3.47-6.14-2.19N/AN/A781.3963.7946.4161.03
ROCE (%)1.39-3.2-5.75-1.99N/AN/A1048.0486.0264.4783.16
Asset Turnover Ratio0.060.050.170.390.616.671.641.072.572.81
PAT to CFO Conversion(x)-0.6N/AN/AN/AN/A1.33-0.383.24-1.950.2
Working Capital Days
Receivable Days228.90280.7062.8012011.80010.2041.8066.70
Inventory Days29.2081.4028.303.800064.9058.4024.9026.50
Payable Days88124.707033.80154.50260.400940551.90235.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nexus Surgical And Medicare Ltd FAQs

The current trading price of Nexus Surgical & Med on 24-Jun-2026 16:59 is ₹19.65.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Nexus Surgical & Med stood at ₹10.75 Cr

The latest P/E ratio of Nexus Surgical & Med as of 23-Jun-2026 is 14.61.

The latest P/B ratio of Nexus Surgical & Med as of 23-Jun-2026 is 5.97.

The 52-week high of Nexus Surgical & Med is ₹25.50 and the 52-week low is ₹13.26.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nexus Surgical & Med is ₹7.87 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nexus Surgical And Medicare Ltd is a average quality company.

The key valuation ratios of Nexus Surgical And Medicare Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nexus Surgical And Medicare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Nexus Surgical And Medicare Ltd

Nexus Surgical and Medicare Limited (Earlier Known as Nexus Commodities and Technology Limited) is a public limited company incorporated in the year 1992 under Companies Act, 1956. Nexus Surgical And Medicare Limited also listed on the Bombay Stock Exchange.

Business area of the company

The company is engaged in the business of trading activities in various commodities within India.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: